Encompass Health Corporation

NYSE:EHC Stock Report

Market Cap: US$9.5b

Encompass Health Balance Sheet Health

Financial Health criteria checks 4/6

Encompass Health has a total shareholder equity of $2.7B and total debt of $2.3B, which brings its debt-to-equity ratio to 82.7%. Its total assets and total liabilities are $6.5B and $3.7B respectively. Encompass Health's EBIT is $832.5M making its interest coverage ratio 6. It has cash and short-term investments of $147.8M.

Key information

82.7%

Debt to equity ratio

US$2.25b

Debt

Interest coverage ratio6x
CashUS$147.80m
EquityUS$2.73b
Total liabilitiesUS$3.73b
Total assetsUS$6.46b

Recent financial health updates

Recent updates

Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors

Dec 10
Here's Why Encompass Health (NYSE:EHC) Has Caught The Eye Of Investors

Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings

Oct 21
Encompass Health Corporation's (NYSE:EHC) Price Is Out Of Tune With Earnings

Is Encompass Health (NYSE:EHC) Using Too Much Debt?

Oct 03
Is Encompass Health (NYSE:EHC) Using Too Much Debt?

Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 27
Encompass Health's (NYSE:EHC) Shareholders Will Receive A Bigger Dividend Than Last Year

Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17

Aug 10
Encompass Health (NYSE:EHC) Will Pay A Larger Dividend Than Last Year At $0.17

These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well

Jun 27
These 4 Measures Indicate That Encompass Health (NYSE:EHC) Is Using Debt Reasonably Well

Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?

Jun 09
Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?

Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price

May 23
Encompass Health Corporation's (NYSE:EHC) Business Is Yet to Catch Up With Its Share Price

Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next

Apr 26
Encompass Health Corporation Just Beat EPS By 20%: Here's What Analysts Think Will Happen Next

Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 11
Is Encompass Health Corporation (NYSE:EHC) Expensive For A Reason? A Look At Its Intrinsic Value

Encompass Health's (NYSE:EHC) Dividend Will Be $0.15

Mar 09
Encompass Health's (NYSE:EHC) Dividend Will Be $0.15

What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?

Feb 25
What Is Encompass Health Corporation's (NYSE:EHC) Share Price Doing?

Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?

Feb 07
Do Encompass Health's (NYSE:EHC) Earnings Warrant Your Attention?

We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt

Jan 09
We Think Encompass Health (NYSE:EHC) Can Stay On Top Of Its Debt

Encompass Health Corporation: Solid Quarterly Report Makes For A Buy

Aug 14

Encompass Health: Incremental CapEx Adds Tremendous Torque To Flywheel

Aug 07

Encompass Health declares $0.15 dividend

Feb 23

Encompass Health: Incremental Returns On Capital Key, Confirm Buy

Feb 17

Encompass Health 2023 adjusted earnings per share estimate range below consensus

Feb 07

Encompass Health Non-GAAP EPS of $0.67 beats by $0.03, revenue of $1.09B beats by $30M

Oct 26

Encompass Health declares $0.15 dividend

Oct 19

Encompass health to build a rehabilitation hospital in the Villages, Florida

Sep 26

Financial Position Analysis

Short Term Liabilities: EHC's short term assets ($933.9M) exceed its short term liabilities ($897.4M).

Long Term Liabilities: EHC's short term assets ($933.9M) do not cover its long term liabilities ($2.8B).


Debt to Equity History and Analysis

Debt Level: EHC's net debt to equity ratio (77.3%) is considered high.

Reducing Debt: EHC's debt to equity ratio has reduced from 161.3% to 82.7% over the past 5 years.

Debt Coverage: EHC's debt is well covered by operating cash flow (41%).

Interest Coverage: EHC's interest payments on its debt are well covered by EBIT (6x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Encompass Health Corporation is covered by 38 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null RESEARCH DEPARTMENTAvondale Partners
Matthew GillmorBaird
Ishan MajumdarBaptista Research